Outpatient toxicology clinic experience of patients with hip implants

Clinical Toxicology

Volumn 51, Issue 4, 2013, Pages 230-236

  Leikin, J B ^a   Karydes, H C ^b   Whiteley, P M ^c   Wills, B K ^d   Cumpston, K L ^d   Jacobs, J J ^e  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b Adventist Hinsdale Hospital   (United States)

^c Regional Medical Center of San Jose   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RUSH MEDICAL COLLEGE   (United States)

Author keywords

Arthroplasty; Chromium; Cobalt

Indexed keywords

CHROMIUM; COBALT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; FATIGUE; FEMALE; FIBROMYALGIA; HEARING IMPAIRMENT; HIP ARTHROPLASTY; HIP PAIN; HUMAN; MALE; METAL ON METAL HIP ARTHROPLASTIES; MYALGIA; NEUROTOXICITY; OBSERVATIONAL STUDY; OUTPATIENT; RETROSPECTIVE STUDY; TINNITUS; TRACE METAL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; CHROMIUM; COBALT; COHORT STUDIES; FEMALE; HIP PROSTHESIS; HUMANS; ILLINOIS; MALE; METAL-ON-METAL JOINT PROSTHESES; METALS, HEAVY; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; POISONING; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; VIRGINIA;

EID: 84876492618     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2013.768343     Document Type: Article

References (49)

1. http://www/fda.gov/Medical Devices/Safety/Alerts and Notices/ucm335775. htm accessed January 30, 2013.
2. Jacobs J, Skipor A, Amstutz HC, Hallab NJ, Urban RM, Amstutz HC. Can metal levels be used to monitor metal-on-metal hip arthroplasties? J Arthroplasty 2004; 19:59-65. (Pubitemid 39575830)
3. De Smet K, De Haan R, Calistri A, Campbell PA, Ebramzadeh E, Pat-tyn C, Gill HS. Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am 2008; 90:202-208.
4. Oldenburg M, Wegner R, Baur X. Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty 2009; 24 825.e15-825.e20.
5. Tower SS. Arthroprosethetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg Am 2010; 92:2847-2851.
6. Mao X, Wong AA, Crawford RW. Cobalt toxicity-an emerging clinical problem in patients with metal-on-metal hip prostheses? MJA 2011; 194:649-651.
7. Steens W, von Foerster G, Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip-a case report. Acta Orthopaedica 2006; 77:830-832. (Pubitemid 44521928)
8. Underwood R, Matthies A, Cann P, Skinner JA, Hart AJ. A comparison of explanted articular surface replacement and Birmingham hip resurfacing components. J Bone Joint Surg [Br] 2011; 93-B: 1169-1177.
9. Meier B. In medicine, new isn't always improved. New York Time. June 26, 2011, page BU1.
10. Soderman P, Malchau H. Is the Harris hip score system useful to study the outcome of total hip replacement? Clin Orthop Relat Rese 2001; 384:189-197. (Pubitemid 33599782)
11. Whittle DP, El-Dahshan ME, Stringer J. The oxidation behavior of cobalt-base alloys containing dispersed oxides formed by internal oxidation. Corrosion Sci 1977: 17:879-891. (Pubitemid 8574814)
12. Schaffer AW, Pilger A, Engelhardt C, Zweymueller K, Ruediger HW. Increased blood cobalt and chromium after total hip replacement. J Clin Toxicol 1999; 37:839-844. (Pubitemid 30013372)
13. Adami G, Smarrelli D, Martinelli B, Acquavita A, Reisenhofer E. Cobalt blood levels after total hip replacement (THR): a new follow-up study in Trieste (Italy). Ann Chim 2003; 93:1-40.
14. Rising JP, Reynolds IS, Sedrakyan A. Delays and diff culties in assessing metal-on-metal hip implants. N Engl J Med 2012; 367:e1-e3.
15. Barceloux DG. Chromium. J Clin Toxicol 1999; 37:173-194. (Pubitemid 29292905)
16. Barceleau DG. Cobalt. J Clin Toxicol 1999; 37:201-206.
17. Alexander CS. Cobalt-beer cardiomyopathy: a clinical and pathologic study of twenty-eight cases. Am J Med 1972; 53:395-417.
18. Schribmacher UOE. Case of cobalt poisoning. Brit Med J 1967; 1: 545-546.
19. Machado C, Appelbe A, Wood R. Arthroprosthetic cobaltism and car-diomyopathy. Heart Lung Circu 2012; 21:759-760.
20. Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle Nerve 2010; 42:140-143.
21. Pelclova D, Sklensky M, Janicek P, Lach K. Severe cobalt intoxication following hip replacement revision: clinical features and outcome. Clin Toxicol 2012; 50:262-265.
22. Brock T, Stopford W. Bioaccessability of metals in human health risk assessment: evaluating risk from exposure to cobalt compounds. J Environ Monit 2003; 5:71N-76N. (Pubitemid 36981194)
23. Rizzeti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, Padovani A. Loss of sight and sound: could it be the hip? Lancet 2009; 373:1052.
24. Keegan GM, Learmonth ID, Case CP. Orthopaedic metals and their potential toxicity in the arthroplasty patient: a review of current knowledge and future strategies. J Bone J Surg Br 2007; 89: 567-573. (Pubitemid 46958760)
25. Hart AJ, Sabah SA, Bandi AS, Maggiore P, Tarassoli P, Sampson B, A Skinner J. Sensitivity and Specif city of blood cobalt and chromium metal ions for predicting failure of metal-on-metal hip replacement. J Bone Joint Surg (Br) 2011; 93-98:1308-1315.
26. Sampson B, Hart A. Clinical usefulness of blood metal measurements to assess the failure of metal-on-metal hip implants. Ann Clin Bio-chem 2012; 49:118-131.
27. Schaffer AW, Pilger A, Engelhardt C, Zweymueller K, Ruediger HW. Increased blood cobalt and chromium after total hip replacement. J Clin Toxicol 1999; 37:839-844. (Pubitemid 30013372)
28. Catalani S, Rizzetti MC, Padovani A, Apostoli P. Neurotoxicity of cobalt. Hum Exp Toxicol 2012; 31:421-437.
29. Clark M, Prentice J, Paley MN, Hoggard, Stockley I, Wilkinson JM, et al. Effect of circulating metal after metal-on-metal resurfacing on the brain: an MRI study. Orthopedic Research Society 2012 Annual Meeting. Feb 4-7, 2012; San Francisco, Calif. Paper No. 0079.
30. Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mechanisms, effects and management. J Speech Lang Hear Res 2005; 48:1204-1235. (Pubitemid 43190588)
31. Shargorodsky J, Curhan GC, Farwell WR. Prevalence and characteristics of tinnitus among U.S. adults. Am J Med 2010; 123:711-718.
32. Mates JM, Segura JA, Alonso FJ, Marquez J. Roles of dioxins and heavy metal in cancer and neurological diseases using ROS-mediated mechanics. Free Radic Biol Med 2010; 49:1328-1341.
33. Polyzois I, Nikolopoulous D, Michos I, Patsouris E, Theocharis S. Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol 2012; 32:255-269.
34. Daniel J, Holland J, Quigley L, Sprague S, Bhandari M. Pseudotu-mors associated with total hip arthroplasty. J Bone Joint Surg Am 2012; 94:86-93.
35. Langston DJ, Jameson SS, Joyce TJ, Hallab NJ, Natu S, Nargol AV F. Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement. J Bone Joint Surg [Br] 2010; 92-B:38-46.
36. Lombardi Jr AV, Berend KR, Ng VY, Skeels MD, Adams JB, et al. Metal hypersensitivity testing in total joint arthroplasty patients. Scientific exhibit #22. American Academy of Orthopaedic Surgeons Annual Meeting. March 9-13, 2010.
37. Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patient with orthopaedic implants. J Bone Joint Surg 2001; 83:428-436. (Pubitemid 32221575)
38. Benson MKD, Goodwin PG, Brostoff J. Metal sensitivity in patients with joint replacement arthroplasties. Brit Med J 1975; 4:374-375.
39. Atanaskova NA, Tellez A, Molina L, Honari G, Sood A, Barsoum W, Taylor JS. The effect on patchtesting on surgical practices and outcomes in orthopaedic patients with metal implants. Arch Dermatol 2012; 148:687-693.
40. Cooper HJ, Jacobs JJ, Leikin JB, Barden RM, Rosenberg AG, et al. Elevated serum metal levels from vitamin supplementation. J Bone J Surg 2013; 95: In Press.
41. Newton AW, Ranganath I, Armstrong L, Peter V, Roberts NB. Differential distribution of cobalt, chromium and nickel between whole blood, plasma and urine in patients after Metal-on-Metal (MoM) hip arthroplast y. J Orthop Res 2012; 30:1640-1646.
42. Gill HS, Orammatopoulos G, Adshead S, Tsialogiannis E, Tsiridis E. Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends Mol Med 2012; 18:145-155.
43. Lombardi Jr AV, Barrack RL, Berend KR, Cuckler JM, Jacobs JJ, Mont MA, et al. The hip society: Algorithmic approach to diagnosis and management of metal on metal arthroplasty. Scientific Exhibit#06 at the 2012 Annual Meeting of American Academy of Orthopedic Surgeons. San Francisco CA, February 7-11, 2012.
44. Kreibich DN, Moran CG, Delves HT, Owen TD, Pinder IM. Systemic release of cobalt and chromium after uncemented total hip replacement. J Bone Joint Surg (Br) 1996; 78-B:18-21. (Pubitemid 26028687)
45. Unice KM, Monnot AD, Gaffney SH, Tvermoes BE, Thuett KA, Paustenbach DJ, Finley BL. Inorganic cobalt supplementation: prediction of cobalt levels in whole blood and urine using a biokinetic model. Food Chem Toxicol 2012; 50:2456-2461.
46. Zywiel MG, Brandt JM, Overgaard CB, Cheung AC, Turgeon TR, Syed KA. Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. Bone Joint J 2013; 95-B:31-37
47. Macpherson GJ, Breusch SJ. Metal-on-metal hip resurfacing: a critical review. Arch Orthop Trauma Surg 2011; 131:101-110.
48. Strurup J, Dahl LB, Jensen KE, Larsen AB, Gebuhr P. Few adverse reactions to metal-on-metal articulation in total hip arthroplasty in a review study on 358 consecutive cases with 1 to 5 years follow-up. Open Orthop J 2012; 6:366-370.
49. Ardaugh BM, Graves SE, Redberg RF. The 510(k) ancestry of a metal-on-metal hip implant. NEJM 2013; 368:97-100.